Cargando…
Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma
BACKGROUND: FOLFOX is a combinational regimen of folinic acid (FnA, FOL), fluorouracil (5-Fu, F) and oxaliplatin (OxP, OX), and has been long considered as the standard treatment of colorectal cancer (CRC) and hepatocellular carcinoma (HCC). Recent developments of nano delivery systems have provided...
Autores principales: | Guo, Jianfeng, Yu, Zhuo, Sun, Dandan, Zou, Yifang, Liu, Yun, Huang, Leaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786897/ https://www.ncbi.nlm.nih.gov/pubmed/33407548 http://dx.doi.org/10.1186/s12943-020-01297-0 |
Ejemplares similares
-
A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer
por: Sun, Dandan, et al.
Publicado: (2022) -
Exploiting metabolic inhibition to eradicate residual tumors after chemo-immunotherapy
por: Habtetsion, Tsadik, et al.
Publicado: (2014) -
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
por: Xiang, Jiajia, et al.
Publicado: (2023) -
Immunogenetics special issue 2023: Immunogenetics of infectious disease
por: Norman, Paul J.
Publicado: (2023) -
TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition
por: D’Orsogna, L. J., et al.
Publicado: (2011)